Average Co-Inventor Count = 5.99
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (9 from 1,535 patents)
2. Neurogen Corporation (5 from 305 patents)
3. Other (1 from 832,680 patents)
4. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
5. Karos Pharmaceuticals, Inc. (3 patents)
15 patents:
1. 9150556 - Benzimidazolone chymase inhibitors
2. 9073895 - Biarylamide inhibitors of leukotriene production
3. 8829200 - Benzimidazole inhibitors of leukotriene production
4. 8772304 - Benzimidazole inhibitors of leukotriene production
5. 8658661 - Oxadiazole inhibitors of leukotriene production
6. 8618300 - Indolizine inhibitors of leukotriene production
7. 8580829 - Oxadiazole inhibitors of leukotriene production
8. 8580825 - Oxadiazole inhibitors of leukotriene production
9. 8575201 - Oxadiazole inhibitors of leukotriene production
10. 7074799 - Substituted quinazolin-4-ylamine analogues
11. 7034034 - Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives
12. 6436932 - Aminoalkyl substituted pyrrolo[3,2-e] pyridine and pyrrolo[2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
13. 6372743 - Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines
14. 6310063 - Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
15. 6221875 - Substituted 9H-pyridino [2,3-B]indole and 9H-pyrimidino [4,5-B]indole derivatives: selective neuropeptide Y receptor ligands